Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
about
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformThe Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to BrainTowards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor VaccinesBone Regeneration from PLGA Micro-NanoparticlesPolymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypesNanotechnology applications in urology: a reviewStrategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and marketA new prospect in cancer therapy: targeting cancer stem cells to eradicate cancerTargeted therapy using nanotechnology: focus on cancerMesoscale nanoparticles selectively target the renal proximal tubule epitheliumNanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitisPolymeric nanoparticles for targeted treatment in oncology: current insightsNovel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitroA Facile Approach to Functionalize Cell Membrane-Coated NanoparticlesProtease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.Extracellularly activatable nanocarriers for drug delivery to tumors.Biomedical Applications of Biodegradable Polymers.Boron polylactide nanoparticles exhibiting fluorescence and phosphorescence in aqueous medium.Current advances in research and clinical applications of PLGA-based nanotechnology.Synthesis of size-tunable polymeric nanoparticles enabled by 3D hydrodynamic flow focusing in single-layer microchannelsRapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution.Ultra-high throughput synthesis of nanoparticles with homogeneous size distribution using a coaxial turbulent jet mixerIntravenously administered nanoparticles increase survival following blast trauma.Polymeric nanoparticles for pulmonary protein and DNA delivery.Anticancer drug-incorporated layered double hydroxide nanohybrids and their enhanced anticancer therapeutic efficacy in combination cancer treatmentControlled synthesis of camptothecin-polylactide conjugates and nanoconjugatesEnhanced MRI T 2 Relaxivity in Contrast-Probed Anchor-Free PEGylated Iron Oxide Nanoparticles.Poly(ethylene glycol) with observable sheddingBiomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord.Polymer--cisplatin conjugate nanoparticles for acid-responsive drug deliveryAptamer-targeted cell-specific RNA interferenceInvestigation of endocytosis and cytotoxicity of poly-d, l-lactide-poly(ethylene glycol) micro/nano-particles in osteoblast cells.Optical imaging-guided cancer therapy with fluorescent nanoparticlesFormulation/preparation of functionalized nanoparticles for in vivo targeted drug delivery.The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticlesCell-type-specific, Aptamer-functionalized Agents for Targeted Disease TherapyProstate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.Self-assembled lipid nanomedicines for siRNA tumor targeting.A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment.
P2860
Q24596232-F5AA6ED4-2510-469B-8778-003B04467DC0Q26745586-238A9276-B284-4736-A0E6-016E84E377AFQ26773073-A9FE8074-8264-4162-841C-C280CA7F8054Q26778233-A1BA17DD-011E-4613-921F-66A0C1587E99Q26830537-49FEA6BD-2EBB-484D-B2F8-29A410B22CD6Q27009446-B480D5D2-3E4C-4143-BF7D-83B6ECC820F4Q27015050-C19EB1F9-B144-4AE3-A874-B2A9A1FE9572Q27022134-AA5725EA-B212-4859-990D-4404C53512BCQ27023361-77953F6F-AE69-417C-8B08-AFDE81F3AA30Q27335127-D331459F-8416-4D77-90E3-4E88F32D23D3Q28086953-B0AA6793-AF0C-46D5-A26E-E5E26150157AQ28087243-1814A1AE-158B-4146-B259-BEF4FC37B1D5Q28476756-5113B1D6-45C8-4A47-BC79-D9D3EDEEBC14Q28833663-E3433EAA-B071-4435-B762-9E73A53DF323Q30355600-09111A03-F960-4EDB-B198-DB121C5080B9Q30401826-FC03C543-9B63-4E51-AA8E-BE9172391A70Q30426452-2A544F6B-C5AE-45A4-869D-E5BA113EEE09Q30440645-4F98EA92-8B00-4996-A12B-38E72985709AQ30482916-11FF0C41-8EDD-4D2D-825D-5D8C201DB74FQ30501637-39CFCFD9-AD98-4D1C-88A9-176F638F4C77Q30524254-AB9958F5-7CBD-40E5-B129-906F64F004F9Q30581724-CDC23502-2516-4670-8D72-BECFCE4B23C2Q30584438-9C5658D1-5E37-41ED-B790-CF649B80A6EAQ33560960-07428453-C3AD-4F63-9BA5-820CCB409F0DQ33593987-C1CCFF43-8848-4546-8FD4-121B70CDB029Q33601744-DD66DB20-FAFB-4DFC-B446-E1B47FEE0799Q33609943-35D15A40-85F3-4D6F-832B-A41A310FDCF9Q33647205-99A3E613-F586-420B-AFBC-542D19B5BC40Q33653678-E7CE476E-1D24-4BD5-BF77-510A2A106B2FQ33695863-5C31ECB7-1EE4-484B-9579-74BFA2EF81DDQ33717239-BB4D412E-CE52-42C3-B4EC-7B2183691CB8Q33721938-19276293-475C-4564-BDCD-BD6432064838Q33731037-5442A06C-4141-492F-9CFD-6865B1EE4862Q33760895-4342711B-3232-4BA4-ABE7-B9CBE815B2DFQ33772783-6B34831C-ABEF-4C4C-A8E4-A71ECD437C93Q33834772-28B250DD-34AD-4875-B211-6F19B5495152Q33893647-CDD130EF-2C1D-4A67-80F9-BAB117C863D5Q33902253-74AECE08-9DDC-46CE-94D5-8878B4DAEC34Q33907953-31164833-46E6-4DE6-8570-AFDBB733EAA0Q33949801-D5E8D4B6-3FB6-419D-A65F-EAC0EE304B75
P2860
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
@en
type
label
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
@en
prefLabel
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
@en
P2093
P2860
P1433
P1476
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
@en
P2093
Aleksandar F Radovic-Moreno
Benjamin A Teply
Etgar Levy-Nissenbaum
Frank X Gu
Gaurav Luther
Ines Sherifi
Jianjun Cheng
Josephine Sung
Robert Langer
P2860
P304
P356
10.1016/J.BIOMATERIALS.2006.09.047
P577
2006-10-20T00:00:00Z